2,2 AORThe respondents who were less than 15 years were twice more likely to receive malaria vaccination when compared with those who were 15 years and above (AOR=2.2, 95%CI: 1.1–4.7).
Nigeriapaludismeobservé 2023publié 2025African health sciencesPubMeddocument de 6 observations
97,8 %Using microscopy as the gold standard, the sensitivity of SD-Bioline™ mRDT for malaria diagnosis was 97.8%.
Nigeriapaludismepublié 2021Nigerian journal of clinical practicePubMeddocument de 18 observations
64,24 %Le traitement par l'extrait de dichlorométhane d'écorce de tige de Commiphora africana a entraîné un taux de suppression des parasites de 64,24 % chez des souris infectées par Plasmodium berghei.
NigeriapaludismeHAL · Unilimdocument de 173 observations
50,8 %Among the 303 health workers surveyed, 154 (50.8%) prescribed artemisinin-based combination therapy (ACT) to patients with negative malaria rapid diagnostic test (mRDT) results within six months preceding the survey.
Nigeriapaludismeobservé six months preceding the surveypublié 2019PloS onePubMeddocument de 8 observations
87,5 %The prevalence of wild-type mdr1 D1246Y allele was 87.5% among Plasmodium falciparum isolates in the studied Nigerian population.
Nigeriapaludismepublié 2024Malaria journalPubMeddocument de 7 observations
17 casesHyponatraemia occurred in 17 out of 51 children with cerebral malaria.
Nigeriapaludismepublié 1997African journal of medicine and medical scienceseurope_pmcdocument de 7 observations
61,1 %Malaria was the most frequent diagnosis, accounting for 293 cases (61.1%).
Nigeriapaludismepublié 2026NephronPubMeddocument de 11 observations
74,2 %Uptake of intermittent preventive treatment in pregnancy (IPTp) was 74.2% among women of reproductive age in Ebonyi State, Nigeria.
Nigeriapaludismepublié 2019BMC pregnancy and childbirthPubMeddocument de 10 observations
25 μg/mLL'extrait éthanolique de graines de Peganum harmala inhibe Plasmodium falciparum à 97,4 % pour une concentration de 25 μg/mL.
NigeriapaludismeHAL · Unilimdocument de 173 observations
14,3 %Triple mutant + wild genotype CVIET + CVMNK was observed in 14.3% of Pfcr t isolates.
Nigeriapaludismepublié 2024BMC research notesPubMeddocument de 10 observations
37 %In 37% of patients with Plasmodium falciparum malaria, the parasite count was over 10,000 microliters-1.
Nigeriapaludismepublié 1990Annals of Tropical Medicine and ParasitologyOpenAlexdocument de 13 observations
52,7 %The funding shortfall for national malaria interventions in Nigeria from 2018 to 2020 was 52.7% of the needs.
Nigeriapaludismeobservé 2018-2020publié 2023Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/s12936-023-04641-z
Chlorpheniramine reversed chloroquine resistance in vitro in a similar manner to verapamil in isolates of P. falciparum obtained from the patients.
Nigeriapaludismepublié 1997Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 4 observations
0,25 µmol/litreThe IC50 of quinine against Nigerian Plasmodium falciparum isolates was 0.25 µmol per litre.
Nigeriapaludismepublié 1988Transactions of the Royal Society of Tropical Medicine and HygieneOpenAlexdocument de 5 observations
32 %Left ventricular diastolic dysfunction assessed by abnormal mitral annular plane systolic excursion (MAPSE) was more common in children with severe malaria than in controls (32% vs 13%).
Nigeriapaludismepublié 2026European journal of pediatricsPubMeddocument de 5 observations
36,7 %In children who received artesunate-amodiaquine, 36.7% had an immediate rise in peripheral parasitaemia within 0–4 hours after treatment.
Nigeriapaludismepublié 2010Malaria journaleurope_pmcdocument de 2 observationsDOI 10.1186/1475-2875-9-335
4,2 %Among 119 children with Plasmodium falciparum infection in Lagos, Nigeria, 4.2% had a mixture of genotypes encoding CVMNK and CVIET.
Nigeriapaludismepublié 2015Diagnostic pathologyeurope_pmcdocument de 5 observations
Serum levels of 8-iso PGF2α were significantly elevated in COVID-19 patients co-infected with malaria compared to COVID-19 patients without malaria.
NigeriaCOVID-19 · paludismepublié 2020The Pan African medical journalPubMeddocument de 3 observations
34,4 %The sensitivity of rapid diagnostic test (RDT) for asymptomatic malaria detection was 34.4% compared to polymerase chain reaction (PCR) as ground truth.
Nigeriapaludismepublié 2026Journal of community healthPubMeddocument de 13 observations
All regimens — artemether-lumefantrine, artesunate-amodiaquine co-formulated, and artesunate-amodiaquine co-packaged — were well tolerated in children under 12 years of age with uncomplicated Plasmodium falciparum malaria.
Nigeriapaludismepublié 2011The American journal of tropical medicine and hygieneeurope_pmcdocument de 7 observationsDOI 10.4269/ajtmh.2011.10-0582
23,6 %Among children under 10 years, malaria prevalence was 23.6% by microscopic test in rural communities of Ebonyi State, Nigeria.
Nigeriapaludismepublié 2022The Korean journal of parasitologyPubMeddocument de 10 observations
34,2 %Overall Plasmodium malariae seroprevalence among children aged 0–14 years in Nigeria was 34.2%.
Nigeriapaludismepublié 2023Nature communicationsPubMeddocument de 6 observations
200 genotypesGlobal searches have identified almost 200 different non-synonymous mutant pfk13 genotypes.
Nigeriapaludismepublié 2019BMC medicineeurope_pmcdocument de 8 observationsDOI 10.1186/s12916-018-1207-3
115 casesAmong 193 children aged ≤1–15 years presenting with symptoms suggestive of malaria in Ilorin, Nigeria, 115 (59.6%) had Plasmodium falciparum infections.
Nigeriapaludismepublié 2024Acta parasitologicaPubMeddocument de 5 observations
1 copyAll pre- and posttreatment samples as well as gametocytes harbored a single copy of the Pfmdr1 gene.
Nigeriapaludismepublié 2009Antimicrobial agents and chemotherapyeurope_pmcdocument de 5 observationsDOI 10.1128/aac.00968-08
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.